Special Early Bird Rate Ends in....


Welcome to the 4th Gene Therapy Analytical Development Europe Summit

Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4th Annual Gene Analytical Development Europe Summit is the industry’s definitive and only meeting focused on tackling the greatest analytical development challenges in the context of gene therapy drug development.

Hear from the likes of AstraZeneca, MHRA, Gyroscope, REGENXBIOBiogen, Spark Therapeutics, and more across three days and two tracks of in-depth case studies, interactive panel discussions, dedicated Q&A time, and highly appraised networking opportunities to meet and learn from the leaders of this pioneering field.

Don’t miss the opportunity to network with 80+ analytical experts to overcome your analytical challenges encountered in every stage of the gene therapy development life cycle.

astrazeneca-logo-png-astrazeneca-logo-astra-zeneca-4902 (1)

“The event was well organised with inspiring speakers and quality information was discussed over the course of the event”AstraZeneca

2023 Expert Speaker Faculty Includes

Franz Schnetzinger

Executive Director


Janet Glassford

Senior Quality Assessor

Medicines & Healthcare Products Regulatory Agency (MHRA)

Jeroen van der Velden

Assay Development & Team Lead

Amarna Therapeutics

Kam Tse

Director, Analytical Development

PTC Therapeutics

Susumu Uchiyama


Osaka University

2023 Partners

logo GPT high res

Other Events In the Series: